Evidence map›Paper›PMID 42128951›Full record

ReviewCurrent psychiatry reports2026

Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care.

Jamarie A Geller, Rachel Pacilio, Amanda E Downey, Anya Ragnhildstveit, Marissa Raymond-Flesch, Stephanie Knatz-Peck, Natalie Gukasyan

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current psychiatry reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jamarie A GellerDepartment of Psychiatry, The University of Michigan, 1500 E Medical Center Dr, Ann Arbor, MI, 48109, USA. jageller7@gmail.com.ORCID http://orcid.org/0000-0001-9049-4400
Rachel PacilioDepartment of Psychiatry, The University of Michigan, 1500 E Medical Center Dr, Ann Arbor, MI, 48109, USA.ORCID http://orcid.org/0000-0001-6568-267X
Amanda E DowneyDepartment of Pediatrics, University of California, San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-5206-7798
Anya RagnhildstveitCenter for Psychedelic Research, Pneuma Science, Draper, UT, USA.ORCID http://orcid.org/0000-0002-5796-3428
Marissa Raymond-FleschDepartment of Pediatrics, University of California, San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-0037-8970
Stephanie Knatz-PeckDepartment of Psychiatry, University of California, San Diego, San Diego, CA, USA.ORCID http://orcid.org/0000-0001-9421-9158
Natalie GukasyanNew York State Psychiatric Institute, Columbia University Medical Center, New York, NY, USA.ORCID http://orcid.org/0000-0003-3567-1421

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThere is growing evidence that psychedelics and associated treatment modalities may offer therapeutic benefits across a range of psychiatric conditions. Anorexia nervosa (AN), a serious and often treatment-resistant illness associated with significant morbidity and mortality, is one such condition for which psilocybin-assisted therapy (PAT) may hold promise. RECENT

findingsTo date, research on PAT for AN has focused primarily on adults, despite the fact that AN frequently begins in adolescence, and early age of onset portends poorer prognosis, including more severe AN, more lifetime psychiatric comorbidity, and greater life difficulties. Given these risks, an exploration of the theoretical potential of PAT for adolescent populations is warranted. Important considerations include biological implications, developmental stage, and consent. Adaptations to the current models of psilocybin-assisted therapy in studies of adults are proposed, and emerging models that address the unique challenges of these patients are discussed.

Indexed as

Anorexia NervosaHallucinogensPsilocybinAdolescentHumansHallucinogensPsilocybinAdolescent psychiatryAnorexia nervosaPsilocybinPsychedelic therapy

Identifiers

PMID42128951
PMCPMC13171658

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.